//
sign in
Post
by @danabra.mov
PostEmbed
by @danabra.mov
Record
by @jimpick.com
Record
by @atsui.org
+ new component
Post
Asthma & Obesity New research presented at #ECO2026 shows the use of the new GLP-1 class of obesity drugs by people with asthma is associated with a 26% fall in the number of asthma exacerbations & a 14% drop in use of asthma inhaler relievers.
4d
eco-newsletter.co.uk
New research presented at ECO shows the use of the new GLP-1 class of obesity drugs in people with asthma is associated with a 26% fall in the number of asthma exacerbations and a 14% drop in use o…
Study links use of new obesity drugs to reduction of asthma exacerbations and inhaler use – ECO 2026 Newsletter
The European Association for the Study of Obesity